Debanti Sengupta currently serves as the Senior External Innovation Director at Varian, where she plays a pivotal role in shaping the future of oncology and immuno-oncology through strategic partnerships and innovative projects. With her extensive expertise in molecular diagnostics, digital health, and targeted therapies, Debanti...
Debanti Sengupta currently serves as the Senior External Innovation Director at Varian, where she plays a pivotal role in shaping the future of oncology and immuno-oncology through strategic partnerships and innovative projects. With her extensive expertise in molecular diagnostics, digital health, and targeted therapies, Debanti leads translationally focused search-and-evaluation activities in collaboration with Corporate Development. Her ability to conduct thorough due diligence on high-value targets—often exceeding $500 million in enterprise value—demonstrates her proficiency in assessing strategic fit, technical viability, market potential, and financial modeling.
In her role, Debanti has successfully spearheaded partnership discussions, acting as the deal lead for multiple initiatives that align with Varian's vision of advancing cancer care. Her strong background in scientific and medical affairs, combined with her skills in building industry partnerships and managing relationships with key opinion leaders (KOLs), allows her to effectively bridge the gap between scientific innovation and commercial viability. Debanti's technical expertise spans a variety of disciplines, including fluorescence, confocal microscopy, nanotechnology, and protein purification, enabling her to evaluate cutting-edge technologies and their applications in oncology.
Through her leadership, Debanti is not only driving Varian's strategic initiatives but also contributing to the broader landscape of cancer treatment. Her commitment to fostering collaboration within the industry ensures that Varian remains at the forefront of delivering innovative solutions that enhance patient outcomes and redefine the standards of care in oncology.
